Literature DB >> 19794509

Neurodegenerative disease. Genetic discrimination in Huntington disease.

Stefan M Pulst1.   

Abstract

A survey conducted in Canada examined the prevalence of perceived genetic discrimination against patients with Huntington disease. The respondents reported discrimination not only by insurance or mortgage companies, but also in family and social contexts. Discrimination was more frequently attributed to family history than to genetic test results.

Entities:  

Mesh：

Year:  2009        PMID： 19794509     DOI： 10.1038/nrneurol.2009.153

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  8 in total

1.  Discrimination as a consequence of genetic testing.

Authors:  P R Billings; M A Kohn; M de Cuevas; J Beckwith; J S Alper; M R Natowicz
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients.

Authors:  S Taylor; S Treloar; K Barlow-Stewart; M Stranger; M Otlowski
Journal:  Clin Genet       Date:  2008-05-19       Impact factor: 4.438

3.  Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom.

Authors:  L Low; S King; T Wilkie
Journal:  BMJ       Date:  1998-12-12

4.  Gender differences in attitudes among those at risk for Huntington's disease.

Authors:  Sandra Taylor
Journal:  Genet Test       Date:  2005

5.  The new subjective medicine: taking the patient's point of view on health care and health.

Authors:  Mark Sullivan
Journal:  Soc Sci Med       Date:  2003-04       Impact factor: 4.634

6.  Verification of consumers' experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing.

Authors:  Kristine Barlow-Stewart; Sandra D Taylor; Susan A Treloar; Mark Stranger; Margaret Otlowski
Journal:  Genet Med       Date:  2009-03       Impact factor: 8.822

7.  The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.

Authors:  Jeanne C Latourelle; Mei Sun; Mark F Lew; Oksana Suchowersky; Christine Klein; Lawrence I Golbe; Margery H Mark; John H Growdon; G Frederick Wooten; Ray L Watts; Mark Guttman; Brad A Racette; Joel S Perlmutter; Anwar Ahmed; Holly A Shill; Carlos Singer; Stefano Goldwurm; Gianni Pezzoli; Michela Zini; Marie H Saint-Hilaire; Audrey E Hendricks; Sally Williamson; Michael W Nagle; Jemma B Wilk; Tiffany Massood; Karen W Huskey; Jason M Laramie; Anita L DeStefano; Kenneth B Baker; Ilia Itin; Irene Litvan; Garth Nicholson; Alastair Corbett; Martha Nance; Edward Drasby; Stuart Isaacson; David J Burn; Patrick F Chinnery; Peter P Pramstaller; Jomana Al-hinti; Anette T Moller; Karen Ostergaard; Scott J Sherman; Richard Roxburgh; Barry Snow; John T Slevin; Franca Cambi; James F Gusella; Richard H Myers
Journal:  BMC Med       Date:  2008-11-05       Impact factor: 8.775

8.  Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.

Authors:  Yvonne Bombard; Gerry Veenstra; Jan M Friedman; Susan Creighton; Lauren Currie; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  BMJ       Date:  2009-06-09
  8 in total
  2 in total

1.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

Review 2.  Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.

Authors:  Rashad Hussain; Hira Zubair; Sarah Pursell; Muhammad Shahab
Journal:  Brain Sci       Date:  2018-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.